Trial · NCT01674140
Results by group236
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 236
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Invasive Disease-Free Survival (IDFS) | Placebo | 74.4 | 95% Confidence Interval 71.1 to 77.4 | percentage of participants | |
| Invasive Disease-Free Survival (IDFS) | Everolimus | 74.9 | 95% Confidence Interval 71.3 to 78.0 | percentage of participants | |
| Overall Survival (OS) | Placebo | 85.8 | 95% Confidence Interval 82.9 to 88.2 | percentage of participants | |
| Overall Survival (OS) | Everolimus | 88.1 | 95% Confidence Interval 85.3 to 90.3 | percentage of participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Abdominal pain | 1 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Abdominal pain | 7 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Alanine aminotransferase increased | 1 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Alanine aminotransferase increased | 4 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Allergic reaction | 0 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Allergic reaction | 2 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Anemia | 0 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Anemia | 10 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Anxiety | 1 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Anxiety | 0 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Appendicitis | 2 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Appendicitis | 1 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Appendicitis perforated | 0 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Appendicitis perforated | 2 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Placebo | Arthralgia | 1 | Participants | |
| Toxicity Based on Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, Assessed up to 10 Years. | Everolimus | Arthralgia | 5 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01674140/results